Literature DB >> 21157181

Properties and functions of the nucleocapsid protein in virus assembly.

Delphine Muriaux1, Jean-Luc Darlix.   

Abstract

HIV-1 nucleocapsid protein (NC) is a small basic protein generated by the cleavage of the Gag structural polyprotein precusor by the viral protease during virus assembly in the infected cell. HIV-1 NC possesses two copies of a highly conserved CCHC zinc finger (ZnF), flanked by basic residues. HIV-1 NC and more generally retroviral NC proteins are nucleic acid binding proteins possessing potent nucleic acid condensing and chaperoning activities. As such NC protein drives critical structural rearrangements of the genomic RNA, notably RNA dimerization in the course of virus assembly and viral nucleic acid annealing required for genomic RNA replication by the viral reverse transcriptase (RT). Here we review the relationships between the 3D structure of HIV-1 NC, notably the central globular domain encompassing the two zinc fingers and the basic linker and NC functions in the early and late phases of virus replication. One of the salient feature of the NC central globular domain is an hydrophobic plateau which appears to orchestrate the NC functions, such as chaperoning the conversion of the genomic RNA into viral DNA by RT during the early phase, and driving the selection and dimerization of the genomic RNA at the initial stage of viral particle assembly. This ensures a bona fide trafficking of early GagNC-genomic RNA complexes to the plasma membrane of the infected cell and ultimately virion formation and budding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157181      PMCID: PMC3073333          DOI: 10.4161/rna.7.6.14065

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  145 in total

Review 1.  Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Jaisri R Lingappa
Journal:  AIDS Rev       Date:  2007 Jul-Sep       Impact factor: 2.500

2.  Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress.

Authors:  Dorothée Molle; Carolina Segura-Morales; Gregory Camus; Clarisse Berlioz-Torrent; Jorgen Kjems; Eugenia Basyuk; Edouard Bertrand
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

3.  The ESCRT pathway and HIV-1 budding.

Authors:  Yoshiko Usami; Sergei Popov; Elena Popova; Michio Inoue; Winfried Weissenhorn; Heinrich G Göttlinger
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

4.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2.

Authors:  Melissa Batonick; Manuel Favre; Michael Boge; Paul Spearman; Stefan Höning; Markus Thali
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

6.  Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.

Authors:  Karolína Bohmová; Romana Hadravová; Jitka Stokrová; Roman Tuma; Tomás Ruml; Iva Pichová; Michaela Rumlová
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

7.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC).

Authors:  N Morellet; H Déméné; V Teilleux; T Huynh-Dinh; H de Rocquigny; M C Fournié-Zaluski; B P Roques
Journal:  J Mol Biol       Date:  1998-10-23       Impact factor: 5.469

9.  The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle.

Authors:  Ann Brasey; Marcelo Lopez-Lastra; Theophile Ohlmann; Nancy Beerens; Ben Berkhout; Jean-Luc Darlix; Nahum Sonenberg
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Assembly of immature HIV-1 capsids using a cell-free system.

Authors:  Jaisri R Lingappa; Beth K Thielen
Journal:  Methods Mol Biol       Date:  2009
View more
  60 in total

Review 1.  Cell biology of retroviral RNA packaging.

Authors:  Nolwenn Jouvenet; Sébastien Lainé; Lucie Pessel-Vivares; Marylène Mougel
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

2.  Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.

Authors:  Audrey Thomas; Charlotte Mariani-Floderer; Maria Rosa López-Huertas; Nathalie Gros; Elise Hamard-Péron; Cyril Favard; Theophile Ohlmann; José Alcamí; Delphine Muriaux
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

Review 3.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

Review 4.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

5.  Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase.

Authors:  Jiae Kim; Anne Roberts; Hua Yuan; Yong Xiong; Karen S Anderson
Journal:  J Mol Biol       Date:  2011-12-23       Impact factor: 5.469

6.  Budding of retroviruses utilizing divergent L domains requires nucleocapsid.

Authors:  Nana F Bello; Vincent Dussupt; Paola Sette; Victoria Rudd; Kunio Nagashima; Frederic Bibollet-Ruche; Chaoping Chen; Ronald C Montelaro; Beatrice H Hahn; Fadila Bouamr
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

7.  Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein.

Authors:  Elia Gamba; Mattia Mori; Lesia Kovalenko; Alessia Giannini; Alice Sosic; Francesco Saladini; Dan Fabris; Yves Mély; Barbara Gatto; Maurizio Botta
Journal:  Eur J Med Chem       Date:  2017-12-24       Impact factor: 6.514

8.  Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles.

Authors:  Karolína Strohalmová-Bohmová; Vojtěch Spiwok; Martin Lepšík; Romana Hadravová; Ivana Křížová; Pavel Ulbrich; Iva Pichová; Lucie Bednárová; Tomáš Ruml; Michaela Rumlová
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

9.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

10.  The zinc fingers of YY1 bind single-stranded RNA with low sequence specificity.

Authors:  Dorothy C C Wai; Manar Shihab; Jason K K Low; Joel P Mackay
Journal:  Nucleic Acids Res       Date:  2016-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.